











































Population perspective comparing COVID-19 to all and common
causes of death during the first wave of the pandemic in seven
European countries
Citation for published version:
Olabi, B, Bagaria, J, Bhopal, S, Curry, G, Villarroel, N & Bhopal, R 2021, 'Population perspective comparing
COVID-19 to all and common causes of death during the first wave of the pandemic in seven European
countries', Public Health in Practice. https://doi.org//10.1016/j.puhip.2021.100077
Digital Object Identifier (DOI):
/10.1016/j.puhip.2021.100077
Link:




Public Health in Practice
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 22. Jan. 2021
Population perspective comparing COVID-19 to all and common causes of death in 
seven European countries 
 
Bayanne Olabi1, Jayshree Bagaria2, Sunil S. Bhopal3, Gwenetta D. Curry4,5, Nazmy 
Villarroel6, Raj Bhopal4 
 
1 Department of Dermatology, Lauriston Building, Lauriston Place, Edinburgh, EH3 9EN 
2 Independent Consultant in Global Public Health  
3 Population Health Sciences Institute, Newcastle upon Tyne, NE1 7RU 
4 Usher Institute, University of Edinburgh, EH3 9AG 
5 University of Alabama, Tuscaloosa, AL 35487 
6 University of Sheffield, S10 2TG 
 
Corresponding author: Bayanne Olabi, bayanne@doctors.org.uk  
 
Abstract 
Background: Mortality statistics on the COVID-19 pandemic have led to widespread 
concern and fear. To contextualise these data, we compared mortality related to COVID-19 
with all and common causes of death, stratifying by age and sex. We also calculated deaths as 
a proportion of the population by age and sex.  
Methods: COVID-19 related mortality and population statistics from seven European 
countries were extracted: England and Wales, Italy, Germany, Spain, France, Portugal and 
Netherlands. Available data spanned 14-16 weeks since the first recorded deaths in each 
country, except Spain, where only comparable stratified data over an 8-week time period was 
available. The Global Burden of Disease database provided data on all deaths and those from 
pneumonia, cardiovascular disease combining ischaemic heart disease and stroke, chronic 
obstructive pulmonary disease, cancer, road traffic accidents and dementia.  
Findings: Deaths related to COVID-19, while modest overall, varied considerably by age. 
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0.2% females; Portugal 0.2% males, 0.15% females; and Netherlands 0.6% males, 0.4% 
females.  
Interpretation: Mortality rates from COVID-19 remains low including when compared to 
other common causes of death and will likely decline further while control measures are 
maintained. These data may help people contextualise their risk and policy makers in 
decision-making.   
 
Background  
The COVID-19 pandemic, calamitous though it is, needs to be placed in perspective. It has 
been eight months since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
outbreak was first identified1, and deaths globally continue to rise. As of 28 July 2020, there 
have been 16,523,029 cases and 654,860 directly attributable deaths worldwide2. These 
statistics have caused widespread concern and fear3,4. Some of this concern is clearly 
justified, but some – as we have demonstrated in children – is disproportionate, given that 
COVID-19 caused a small fraction of deaths, even fewer than influenza5.  
 
Contextualising the impact of COVID-19 in relation to other causes of death, and to mortality 
rates in the population, helps to gain perspective. Total mortality related to COVID-19 is the 
most commonly reported statistic, which has been invaluable in galvanising public health 
interventions6; however, given important differentials by age and sex, stratification of 
mortality data is essential7.  
 
We report age- and sex-stratified mortality data related to COVID-19 and compare these with 
all-cause and common causes of mortality using data from the Global Burden of Disease 
(GBD) study8. We examined two perspectives: firstly, mortality from COVID-19 and other 
common causes of death as a fraction of all deaths, and secondly, as a fraction of the 
population. 
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capacity to collect data. Available data spanned 14-16 weeks since the first recorded deaths in 
each country, except Spain, where only comparable stratified data over an 8-week time 
period was available. Furthermore, these countries have had high death rates given their 
average age of the population is high compared with low- and middle-income countries. 
These countries are therefore likely to exemplify the impact of the pandemic at the higher end 
of the mortality scale. Most other countries, especially with younger populations, can 
anticipate lower mortality. 
 
We extracted annual age- and sex-specific death counts from the most recent Global Burden 
of Disease study8 for all causes and pneumonia, cardiovascular disease combining ischaemic 
heart disease and stroke (CVD), chronic obstructive pulmonary disease (COPD), cancer, road 
traffic accidents (RTA) and dementia; these six causes were selected as they represent 
common causes of death10.  
 
To compare mortality estimates from the GBD with those from COVID-19, mortality rates 
for non-COVID-19 causes for each country were adjusted based on the number of weeks 
COVID-19 data were available for (Supplementary Table 1).  
 
Data were analysed by country, age and sex with deaths related to COVID-19 and to other 
specific causes as a fraction of both all causes of death and population size. Data extraction 
and analysis was carried out by BO and checked independently by JB. Butterfly charts with 
stacked bars display these data graphically. 
 
Results 
Table 1 shows mortality by cause, age and sex in the seven countries from 09/03/2020 until 
09/07/2020 (for specific dates see Supplementary Table 1) and the percentage of COVID-19 
deaths and other causes of death with respect to all-cause mortality. Figure 1 summarises 
these data.  
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age of 70, COVID-19 was never the commonest cause of death although it was an important 
contributor.  
 
Figure 2 shows the percentage of the population who died from COVID-19 and the six other 
causes (Supplementary Figure 1 provides continuous x-axes to 100%). These figures show 
that, cumulatively, mortality from the six common causes of death was less than 1% in every 
age group, except in those aged over 80 years, where this percentage ranged from 1-4%. The 
percentage of the population dying from COVID-19 was less than 0.2% in every age group 
under the age of 80 across all countries, less than or equal to 0.1% under the age of 70 and 
less than 0.04% under the age of 60. In each country, over the age of 80, these proportions 
were: England and Wales 1.27% males, 0.87% females; Italy 0.6% males, 0.38% females; 
Germany 0.13% males, 0.09% females; France 0.39% males, 0.2% females; Portugal 0.2% 
males, 0.15% females; and Netherlands 0.6% males, 0.4% females. 
 
Graphical representation of the data from Spain are shown in Supplementary Figure 2, as 
these represent an 8-week time period, compared to other countries, which represent data 
over 14-16 weeks.  
  
Discussion  
The COVID-19 pandemic is an international emergency warranting a comprehensive, 
medical, public health and economic response11. Our methods and analyses provide a 
population perspective on the pandemic in, arguably, to date some of the worst affected 
countries in the world. These data show that the high level of mortality is primarily seen in 
older adults, particularly men. However, even in the most affected groups, other causes of 
death were mostly commoner than COVID-19, and in all groups under the age of 70, 
COVID-19 did not represent the commonest cause of death. Our non-COVID-19 data are not 
current. Given lockdowns, with important limitations on healthcare especially for chronic 
conditions, it may be that mortality from these other causes will be higher in this pandemic 
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pandemic will bring (hopefully both the incidence and mortality rates will continue to 
diminish) but we can see the population impact in relation to mortality so far has been modest 
except in those over 80 years of age. In the immediate future, the relative proportions of 
deaths from COVID-19 compared to other causes in these European countries are likely to 
decline as control measures, while being relaxed, are likely to be applied partially and 
intermittently for some years. 
 
Mortality related to COVID-19 is known to be higher in males than in females and higher in 
older age groups and the mechanisms for these differential effects have been postulated12,13. 
Other important factors have also been recognised to lead to poorer outcomes following 
COVID-19 infection, including co-morbidity14 and ethnicity, with data suggesting that ethnic 
minority groups are at increased risk of death from COVID-1915. Though these have not been 
analysed in this study, ensuring a holistic approach when determining and addressing risk is 
important.  
 
We acknowledge limitations of this study. We found variations between countries in 
proportions of deaths but have not emphasised them as data collection factors may contribute 
to this. For example, the COVID-19 mortality data from France represented only in-hospital 
deaths, whereas England and Wales also counted community deaths, including hospices and 
patients’ homes9. A further limitation is that data from Spain only represented an 8-week time 
span during the initial outbreak, when mortality rates were higher, as their data reporting 
methods changed beyond May9, hindering access to comparable data since then. Defining 
COVID-19 mortality rates is also contentious, as data pertains to clinically apparent PCR-
positive infections, underestimating true mortality16. Furthermore, there may be several 
reasons why the mortality totals exceed 100 in England and Wales, Italy and Spain. The 
cause of death reporting may include more than one of the listed causes of death in this study, 
therefore leading to an overestimation of the cumulative totals. Without access to real-time 
mortality data on all causes, we are also unable to assess the ongoing effect of the pandemic 
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increasing burden of adverse mental health during the pandemic and even contributing to 
suicide risk18,19.  
 
By presenting and interpreting population perspectives on mortality related to COVID-19 
compared with other common causes of death, stratified by age and sex, we have provided 
perspectives to allow policymakers, professionals and the media to tailor both 
communications and interventions to manage the pandemic, including the level of anxiety 
and fear provoked by previously published mortality statistics, primarily daily and cumulative 
totals. Similar analyses are required globally. New work is required to incorporate morbidity 
to produce a broader perspective on the true health impact of COVID-19. 
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Figure 1: Stacked bar charts showing mortality from seven causes of death as a percentage of 
all-cause deaths by age and sex in six European countries. 
 
Figure 2: Stacked bar charts showing mortality data from seven causes of death in six 
countries as a percentage of the population in each demographic group. Discontinuous x-axes 
are used.   
 
Supplementary Figure 1: Stacked bar charts showing mortality data from seven causes of 
death in six countries as a percentage of the population in each demographic group. 
Continuous x-axes are used. 
 
Supplementary Figure 2: Stacked bar charts showing mortality data from Spain (a) as a 
percentage of all cause deaths, and (b) and (c) as a percentage of the population.  
 
Table 1: Mortality data by country, cause, age and sex: specific causes of death, including 
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Supplementary Table 1 
 
Country Start date End date Number of weeks 
England and Wales 13/03/2020 26/06/2020 15.0 
Italy 09/03/2020 30/06/2020 16.0 
Germany 29/03/2020 09/07/2020 14.5 
Spain 22/03/2020 21/05/2020 8.5 
France 21/03/2020 05/07/2020 15.0 
Portugal 23/03/2020 09/07/2020 15.5 
Netherlands 23/03/2020 07/07/2020 15.0 
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